Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension

Free Subscription Articles published in PLoS One Retrieve available abstracts of 44 articles: HTML format

Single Articles

January 2025
1. KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
   Correction: Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
   PLoS One. 2025;20:e0317857.
   PubMed     Abstract available
   
   
   
2. GHAZAIEAN M, Darvishi-Khezri H, Najafi B, Karami H, et al
   Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0318751.
   PubMed     Abstract available
   
   
   
3. YOON DW, Yoon YE, Hwang IC, Lee W, et al
   CT imaging biomarkers to predict severity and prognosis of pulmonary hypertension.
   PLoS One. 2025;20:e0313235.
   PubMed     Abstract available
   
   
   
4. MARTINEZ-PUIG P, Baez-Gutierrez N, Rodriguez-Ramallo H, Abdelkader-Martin L, et al
   Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.
   PLoS One. 2025;20:e0318739.
   PubMed     Abstract available
   
   
   
5. LUIJTEN D, Rodenburg T, Bogaard HJ, Kianzad A, et al
   The value of vector ECG in predicting residual pulmonary hypertension in CTEPH patients after pulmonary endarterectomy.
   PLoS One. 2025;20:e0317826.
   PubMed     Abstract available
   
   
   
6. VIJAYAKUMAR S, Louis DW, Corneau E, Erqou S, et al
   Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings.
   PLoS One. 2025;20:e0321964.
   PubMed     Abstract available
   
   
   
7. MIDDLETON RC, Karpov OA, Fournier M, Kreimer S, et al
   Impact of cardiosphere-derived cells on the maladapted right ventricular muscle in a rat sugen/hypoxia model of pulmonary hypertension with right ventricular dysfunction.
   PLoS One. 2025;20:e0321895.
   PubMed     Abstract available
   
   
   
8. SCHIPS TG, Kavalkovich KW, Yung LM, Ibrahim S, et al
   In vitro and in vivo characterization of wild type BMP9 and a non-osteogenic variant in models of pulmonary arterial hypertension.
   PLoS One. 2025;20:e0329089.
   PubMed     Abstract available
   
   
   
9. CHEN R, Guo D, Pan J, Pang L, et al
   Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators.
   PLoS One. 2025;20:e0330832.
   PubMed     Abstract available
   
   
   
10. CHEN W, Zhang L, Qi H
    CD44 as a novel therapeutic target in pulmonary arterial hypertension: Insights from multi-omics integration and molecular docking.
    PLoS One. 2025;20:e0332817.
    PubMed     Abstract available
    
    
    
11. RIENGVIRODKIJ N, Taechikantaphat M, Ampapol P, Kovorakul T, et al
    Clinical improvement in canine pulmonary hypertension with Perna canaliculus oil (PCSO-524) add-on therapy: Effects on exercise tolerance and cough.
    PLoS One. 2025;20:e0333526.
    PubMed     Abstract available
    
    
    
12. SINNATAMBY T, LaBranche J, Farr-Jones M, Fenske T, et al
    Obstructive airway disorders affecting individuals with hereditary hemorrhagic telangiectasia: A database review.
    PLoS One. 2025;20:e0331690.
    PubMed     Abstract available
    
    
    
13. BERGOT E, Fertin M, Dewavrin MG, Prevot G, et al
    Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose.
    PLoS One. 2025;20:e0331008.
    PubMed     Abstract available
    
    
    January 2024
14. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    PLoS One. 2024;19:e0296068.
    PubMed     Abstract available
    
    
    
15. LIU H, Pan Z, Wu X, Gong C, et al
    Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling.
    PLoS One. 2024;19:e0297525.
    PubMed     Abstract available
    
    
    
16. ZHAN S, Wang L, Wang W, Li R, et al
    Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2024;19:e0299912.
    PubMed     Abstract available
    
    
    
17. YONEDA K, Seki T, Kawazoe Y, Ohe K, et al
    Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan.
    PLoS One. 2024;19:e0300817.
    PubMed     Abstract available
    
    
    
18. MATSUNAGA T, Kono A, Nishio M, Yoshii T, et al
    Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
    PLoS One. 2024;19:e0300716.
    PubMed     Abstract available
    
    
    
19. TURQUIER S, Huot L, Lamkhioued M, Subtil F, et al
    Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.
    PLoS One. 2024;19:e0298727.
    PubMed     Abstract available
    
    
    
20. KRONBERGER C, Willixhofer R, Mousavi RA, Grzeda MT, et al
    The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension.
    PLoS One. 2024;19:e0301483.
    PubMed     Abstract available
    
    
    
21. SHEN T, Ma J, Zhang L, Yu X, et al
    Correction: Positive Feedback-Loop of Telomerase Reverse Transcriptase and 15-Lipoxygenase-2 Promotes Pulmonary Hypertension.
    PLoS One. 2024;19:e0308871.
    PubMed     Abstract available
    
    
    
22. YAMAJI K, Sasaki KI, Nakano M, Yoshiga T, et al
    Catheter-based examination for pulmonary microcirculatory function in patients with pulmonary hypertension.
    PLoS One. 2024;19:e0312609.
    PubMed     Abstract available
    
    
    
23. VASQUEZ MA, Vasquez SJ, Vargas N, Guilliod C, et al
    In-hospital outcomes of cardiac tamponade in patients with pulmonary hypertension: A contemporary analysis.
    PLoS One. 2024;19:e0312245.
    PubMed     Abstract available
    
    
    
24. AULAK KS, Mavarakis L, Tian L, Paul D, et al
    Characteristic disease defects in circulating endothelial cells isolated from patients with pulmonary arterial hypertension.
    PLoS One. 2024;19:e0312535.
    PubMed     Abstract available
    
    
    
25. SHIROTA Y, Ohmori S, Engel JD, Moriguchi T, et al
    GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.
    PLoS One. 2024;19:e0315446.
    PubMed     Abstract available
    
    
    January 2023
26. MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
    Exploration of physical activity knowledge, preferences and support needs among pulmonary hypertension patients.
    PLoS One. 2023;18:e0277696.
    PubMed     Abstract available
    
    
    
27. TAKIGAMI M, Nakanishi N, Tsubata H, Fukai K, et al
    Efficacy and safety of guide extension catheter in balloon pulmonary angioplasty for treatment of complex lesions in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2023;18:e0280683.
    PubMed     Abstract available
    
    
    
28. MURNI IK, Patmasari L, Wirawan MT, Arafuri N, et al
    Outcome and factors associated with undernutrition among children with congenital heart disease.
    PLoS One. 2023;18:e0281753.
    PubMed     Abstract available
    
    
    
29. KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
    Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
    PLoS One. 2023;18:e0282697.
    PubMed     Abstract available
    
    
    
30. YANG Q, Fan W, Lai B, Liao B, et al
    lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease.
    PLoS One. 2023;18:e0281061.
    PubMed     Abstract available
    
    
    
31. TUKPAH AC, Rose JA, Seger DL, Dellaripa PF, et al
    Development and validation of algorithms to build an electronic health record based cohort of patients with systemic sclerosis.
    PLoS One. 2023;18:e0283775.
    PubMed     Abstract available
    
    
    
32. GODA A, Yanagisawa Y, Takeuchi S, Takeuchi K, et al
    Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
    PLoS One. 2023;18:e0286057.
    PubMed     Abstract available
    
    
    
33. KITANO T, Nabeshima Y, Nagata Y, Takeuchi M, et al
    Prognostic value of the right ventricular ejection fraction using three-dimensional echocardiography: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0287924.
    PubMed     Abstract available
    
    
    
34. TSEGA W, Awoke W, Sendekie AK, Dagnew EM, et al
    Electrocardiogram and echocardiography findings and the outcomes of patients with myocardial infarction: Retrospective study in tertiary care hospitals in Northwest Ethiopia.
    PLoS One. 2023;18:e0288698.
    PubMed     Abstract available
    
    
    
35. RAMBARAT P, Zern EK, Wang D, Roshandelpoor A, et al
    Identifying high risk clinical phenogroups of pulmonary hypertension through a clustering analysis.
    PLoS One. 2023;18:e0290553.
    PubMed     Abstract available
    
    
    
36. HENRY DS, Pellegrino RG
    A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
    PLoS One. 2023;18:e0292863.
    PubMed     Abstract available
    
    
    January 2022
37. BOLOURANI S, Sari E, Brenner M, Wang P, et al
    The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
    PLoS One. 2022;17:e0266163.
    PubMed     Abstract available
    
    
    
38. HAYASHI R, Kogiso T, Kikuchi N, Yamamoto K, et al
    Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates.
    PLoS One. 2022;17:e0267125.
    PubMed     Abstract available
    
    
    
39. VICENZI M, Caravita S, Rota I, Casella R, et al
    The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    PLoS One. 2022;17:e0265059.
    PubMed     Abstract available
    
    
    
40. REZENDE CF, Mancuzo EV, Correa RA
    Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension.
    PLoS One. 2022;17:e0268839.
    PubMed     Abstract available
    
    
    
41. TSEGA T, Tesfaye T, Dessie A, Teshome T, et al
    Nutritional assessment and associated factors in children with congenital heart disease-Ethiopia.
    PLoS One. 2022;17:e0269518.
    PubMed     Abstract available
    
    
    
42. CARDOSO NL, de Sa JF, do Nascimento LFE, Mendes LA, et al
    Psychometric properties of the sit-to-stand test for patients with pulmonary hypertension: A systematic review protocol.
    PLoS One. 2022;17:e0275646.
    PubMed     Abstract available
    
    
    
43. JASINSKA-STROSCHEIN M
    Training programs in preclinical studies. The example of pulmonary hypertension. Systematic review and meta-analysis.
    PLoS One. 2022;17:e0276875.
    PubMed     Abstract available
    
    
    
44. RAMSEY SD, Bender MA, Li L, Johnson KM, et al
    Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
    PLoS One. 2022;17:e0278137.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.